Evaluating Treatment Efficacy in a Mouse Model of Enterovirus D68–Associated Paralytic Myelitis
Open accessThe DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
Background: Enterovirus D68 (EV-D68)-associated acute flaccid myelitis (AFM) is a devastating neurological disease for which there are no treatments of proven efficacy. The unpredictable temporal and geographic distribution of cases and the rarity of the disease make it unlikely that data from randomized controlled trials will be available to guide therapeutic decisions. We evaluated the following 3 widely used empirical therapies for the ability to reduce the severity of paralysis in a mouse model of EV-D68 infection: (1) human intravenous immunoglobulin (hIVIG), (2) fluoxetine, and (3) dexamethasone. Methods: Neonatal mice were injected intramuscularly with a human 2014 EV-D68 isolate that reliably induces paralysis in mice due to infection and loss of spinal cord motor neurons. Mice receiving treatments were evaluated for motor impairment, mortality, and spinal cord viral load. Results: hIVIG, which contained neutralizing antibodies to EV-D68, reduced paralysis in infected mice and decreased spinal cord viral loads. Fluoxetine had no effect on motor impairment or viral loads. Dexamethasone treatment worsened motor impairment, increased mortality, and increased viral loads. Conclusion: Results in this model of EV-D68-associated AFM provide a rational basis for selecting empirical therapy in humans and establish this model as a useful system for evaluating other potential therapies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Enterovirus Surveillance - United States, 1970-2005: (540562006-001)
Khetsuriani, N., LaMonte-Fowlkes, A., Oberste, M. S., & Pallansch, M. A. (2006) · PsycEXTRA Dataset · doi:10.1037/e540562006-001 · Cited by 702
Fluoxetine Pharmacokinetics in Pediatric Patients
Wilens, T. E., Cohen, L., Biederman, J., Abrams, A., Neft, D., Faird, N., & Sinha, V. (2002) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200212000-00006 · Cited by 64
Cited by
Enterovirus D68 and acute flaccid myelitis—evaluating the evidence for causality
Messacar, K., Asturias, E. J., Hixon, A. M., Van Leer-Buter, C., Niesters, H. G. M., Tyler, K. L., Abzug, M. J., & Dominguez, S. R. (2018) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(18)30094-x · Cited by 234
Self-citationBrown, D. M., Hixon, A. M., Oldfield, L. M., Zhang, Y., Novotny, M., Wang, W., Das, S. R., Shabman, R. S., Tyler, K. L., & Scheuermann, R. H. (2018) · mBio · doi:10.1128/mbio.01954-18 · Cited by 105
Self-citationCurrent Understanding of Human Enterovirus D68
Sun, J., Hu, X.-Y., & Yu, X.-F. (2019) · Viruses · doi:10.3390/v11060490 · Cited by 81
“Neutralizing antibodies were capable of reducing the paralysis in the mice, and immunosuppressants such as dexamethasone worsened the motor impairment and increased mortality [65,66].”
BackgroundEichinger, A., Hagen, A., Meyer-Bühn, M., & Huebner, J. (2019) · Infection · doi:10.1007/s15010-018-1212-7 · Cited by 60
Metadata
- Authors
- Hixon, A. M., Clarke, P., & Tyler, K. L.
- Venue
- The Journal of Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2017-09-13
- Volume
- 216
- Issue
- 10
- Pages
- 1245-1253
- ISSN
- 0022-1899 (ISSN-L)
- 1537-6613
- OpenAlex
- W2770619585
- Cited by
- 102
- References
- 2
- FWCI
- 7.79
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Evaluating Treatment Efficacy in a Mouse Model of Enterovirus D68–Associated Paralytic Myelitis. https://app.cochat.ai/papers/10.1093/infdis/jix468
- The paper
- Hixon, A. M., Clarke, P., & Tyler, K. L. (2017). Evaluating Treatment Efficacy in a Mouse Model of Enterovirus D68–Associated Paralytic Myelitis. The Journal of Infectious Diseases. https://doi.org/10.1093/infdis/jix468
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.